Five years ago, a group of high-risk skin cancer patients received a bespoke vaccine. The data is finally in, and the results ...
In a small clinical trial, customized mRNA vaccines against high-risk skin cancers appeared to reduce the risk of cancer recurrence and death by nearly 50 percent over five years when compared with ...
Messenger RNA, or mRNA, vaccines entered the public consciousness when they were introduced during the COVID-19 pandemic, and both Pfizer-BioNTech and Moderna used the technology in developing their ...
At the World Economic Forum, CEO Stéphane Bancel expressed concern about the US vaccine market but remained committed to ...
A few years before he took over the U.S. Department of Health and Human Services, Robert F. Kennedy Jr. called COVID-19 shots the "deadliest vaccine ever made." More recently, various anti-vaccination ...
A team of researchers from Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Tsinghua University has unveiled a new messenger ribonucleic acid (mRNA) vaccine ...
Researchers are edging closer to something long imagined but never quite within reach: a single vaccine platform that could be adapted to fight many kinds of cancer. Early experiments in animals and ...
He's lost his father, a brother, aunts, uncles and extended family members to cancer — many of them in their 30s and 40s.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results